(NK) Imerys - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120859
NK: Minerals, Additives, Fillers, Coatings, Binders, Ceramics
Imerys SA is a French multinational company that specializes in providing mineral-based specialty solutions across a wide array of industries. With a rich history dating back to 1880, Imerys has established itself as a leader in the construction materials sector, operating under the ticker symbol NK on the Euronext Paris exchange. As a subsidiary of Belgian Securities BV, the company brings a legacy of expertise and innovation to the table.
Imerys serves a diverse range of sectors including construction and infrastructure, consumer and healthcare, automotive and transportation, energy and electronics, and industrial equipment. Their product portfolio is equally diverse, featuring additives for paints, coatings, and plastics, minerals for ceramics, and advanced materials for high-performance applications. This broad reach underscores their strategic importance across various industries.
From a financial perspective, Imerys boasts a market capitalization of approximately 2.25 billion EUR. While the price-to-earnings ratio is currently zero, which may indicate a unique phase in their financial cycle, the price-to-book ratio of 0.71 and price-to-sales ratio of 0.61 suggest potential undervaluation. These metrics are pivotal for investors assessing the companys financial health and valuation.
Imerys competitive edge lies in its extensive R&D capabilities and global presence, which enable the company to maintain a strong position in the market. Their commitment to innovation and diversified product offerings create significant barriers to entry, making them an attractive consideration for long-term investors seeking stability and growth in the materials sector.
Additional Sources for NK Stock
NK Stock Overview
Market Cap in USD | 2,906m |
Sector | Basic Materials |
Industry | Building Materials |
GiC Sub-Industry | Construction Materials |
IPO / Inception |
NK Stock Ratings
Growth 5y | 16.1% |
Fundamental | -5.58% |
Dividend | 42.3% |
Rel. Strength | 4.32 |
Analysts | - |
Fair Price Momentum | 27.36 EUR |
Fair Price DCF | 8.82 EUR |
NK Dividends
Dividend Yield 12m | 4.52% |
Yield on Cost 5y | 8.18% |
Annual Growth 5y | -4.73% |
Payout Consistency | 93.9% |
NK Growth Ratios
Growth Correlation 3m | 77.4% |
Growth Correlation 12m | -46.3% |
Growth Correlation 5y | 9.5% |
CAGR 5y | 12.28% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | -0.12 |
Alpha | -6.82 |
Beta | 1.357 |
Volatility | 29.13% |
Current Volume | 48.6k |
Average Volume 20d | 73.9k |
As of April 02, 2025, the stock is trading at EUR 29.80 with a total of 48,606 shares traded.
Over the past week, the price has changed by -6.41%, over one month by -3.99%, over three months by +6.66% and over the past year by -0.60%.
Neither. Based on ValueRay Fundamental Analyses, Imerys is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -5.58 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NK as of April 2025 is 27.36. This means that NK is currently overvalued and has a potential downside of -8.19%.
Imerys has no consensus analysts rating.
According to ValueRays Forecast Model, NK Imerys will be worth about 31.4 in April 2026. The stock is currently trading at 29.80. This means that the stock has a potential upside of +5.2%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 38.8 | 30.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 31.4 | 5.2% |